The invention relates to new substituted 6-(2-aminobenzylamino)purines, represented by the general formula I, which can be used in CDK inhibition, in particular, in the treatment of viral infections and diseases involving cell proliferation. The invention further includes pharmaceutical preparations containing substituted 6-(2-aminobenzylamino)purines.
本发明涉及一种新型的取代6-(2-
氨基
苯基
氨基)
嘌呤,其通式为I,可用于CDK抑制,特别是用于治疗病毒感染和涉及细胞增殖的疾病。本发明还包括含有取代的6-(2-
氨基
苯基
氨基)
嘌呤的药物制剂。